Aclarion adds Texas Spine Care Center to CLARITY trial network

Aclarion, Inc. (Nasdaq: ACON, ACONW) has added Texas Spine Care Center as a clinical site in its CLARITY trial, a 300-patient, prospective, randomized, multi-center study evaluating the company's Nociscan platform in patients undergoing surgical treatment for discogenic low back pain.

Texas Spine Care Center is a San Antonio-based orthopedic spine practice with two locations focused exclusively on spine care. The practice joins existing CLARITY sites including Johns Hopkins University, Northwestern Medicine, Advocate Aurora Research Institute, Texas Back Institute, Keck Medicine at USC, UHealth — University of Miami Health System, Scripps Health, and Lanman Spinal Neurosurgery.

"Too often in spine care, we treat what we can see on an MRI without fully accounting for what the image can't tell us. Nociscan changes that by giving us objective, chemical-level insight into which disc is actually generating pain," said Adam Bruggeman, MD, Founder and Orthopedic Spine Surgeon at Texas Spine Care Center.

The CLARITY trial's primary endpoint is change in back pain measured on a 100mm visual analog scale at 12 months compared to baseline. Aclarion said it anticipates an initial internal data readout and expects to publicly disclose early interim results in the fourth quarter of 2026.

The trial's principal investigator is Dr. Nicholas Theodore, Chairman of Neurosurgery at the University of Arizona College of Medicine – Phoenix.

Nociscan is described by Aclarion as a SaaS platform that uses magnetic resonance spectroscopy and augmented intelligence algorithms to help physicians identify painful discs in the lumbar spine.

You May Also Be Interested In

• BMO Capital Starts LB Pharmaceuticals Inc (LBRX) at Outperform
• Inotiv exits Chapter 11 with $326M in debt reduced
• GitLab names Thomas Lloyd as chief business and legal officer